This Is A Custom Widget

This Sliding Bar can be switched on or off in theme options, and can take any widget you throw at it or even fill it with your custom HTML Code. Its perfect for grabbing the attention of your viewers. Choose between 1, 2, 3 or 4 columns, set the background color, widget divider color, activate transparency, a top border or fully disable it on desktop and mobile.

This Is A Custom Widget

This Sliding Bar can be switched on or off in theme options, and can take any widget you throw at it or even fill it with your custom HTML Code. Its perfect for grabbing the attention of your viewers. Choose between 1, 2, 3 or 4 columns, set the background color, widget divider color, activate transparency, a top border or fully disable it on desktop and mobile.
NASH AND PSC

NASH AND PSC

ABOUT US

NASH and PSC

By |October 18th, 2017|About us|

Scott L. Friedman MD, Icahn School of Medicine at Mount Sinai hospital, New York, USA Dr. Friedman is Chief of Liver Diseases and Dean for Therapeutic Discovery at the Icahn School of Medicine at Mount Sinai.  His pioneering research in hepatic fibrosis supported by NIH since 1986, combined with mentoring of over 80 trainees have [...]

Comments Off on NASH and PSC

Systemic sclerosis

By |March 6th, 2017|About us|

Cheif of Advisory Board- Marco Matucci Cerinic MD, PhD, FRCP, FBSRhon, University of Florence, Florence, Italy Marco Matucci-Cerinic is Professor of Rheumatology and Medicine at the Department of Musculoskeletal Medicine , and Director of the Rheumatology Department AVC and of the Division of Rheumatology AOUC, at the Azienda Ospedaliera Universitaria Careggi in Florence, Italy. Dr [...]

Comments Off on Systemic sclerosis

Our Team

By |February 28th, 2016|About us, Uncategorized|

Dr. Adi Mor, CEO and CSO ChemomAb is managed by Dr. Mor, who co-founded the company in 2011. Dr. Mor has extensive knowledge and experience in the fields of immunology, autoimmune and inflammatory diseases and a wide experience in designing, promoting and patenting a novel class of monoclonal antibodies to treat inflammatory and cancer diseases. [...]

Comments Off on Our Team